Showing results (211-220 of 271) with videos related to
Sort By:
Pageof 28
AIDS (London, England)|February 6, 2025
Cerebrospinal fluid biomarkers of inflammation and immune activation associated with neurocognitive impairment among US Latinos with HIVMonica M Diaz, Lily Kamalyan, Tala Al-Rousan, et al.Brain : a Journal of Neurology|December 8, 2022
Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER studyRobert K Heaton, Ronald J Ellis, Bin Tang, et al.The Journal of Infectious Diseases|December 7, 2023
Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIVMattia Trunfio, Bin Tang, Jennifer E Iudicello, et al.Journal of the International Neuropsychological Society : JINS|April 29, 2025
Independent and combined adverse effects of neurocognitive impairment and depression on everyday functioning and quality of life in people with HIVCrystal X Wang, Victoria O Chentsova, Maximo R Prescott, et al.AIDS and Behavior|March 4, 2015
Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV DiseasePariya L Fazeli, Maria J Marquine, Catherine Dufour, et al.AIDS (London, England)|August 19, 2016
HIV-associated neurocognitive disorder is associated with HIV-1 dual infectionGabriel A Wagner, Antoine Chaillon, Siqi Liu, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 29, 2022
Anemia and Erythrocyte Indices Are Associated With Neurocognitive Performance Across Multiple Ability Domains in Adults With HIVOluwakemi K Okwuegbuna, Harpreet Kaur, Iudicello Jennifer, et al.Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|November 8, 2019
Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational StudyElizabeth C Pasipanodya, Jessica L Montoya, Laura M Campbell, et al.AIDS and Behavior|December 16, 2014
Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorderDavid J Moore, Amelia Poquette, Kaitlin B Casaletto, et al.AIDS (London, England)|December 4, 2008
Low atazanavir concentrations in cerebrospinal fluidBrookie M Best, Scott L Letendre, Eileen Brigid, et al.Pageof 28